Hyperscale Data, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Hyperscale Data, Inc. (NYSE American: GPUS) on December 13, 2024. The report details a specific equity financing transaction executed on December 12, 2024, under a pre-existing Securities Purchase Agreement dated November 6, 2023.
Key Financial Metrics and Transaction Details
- Transaction Date: December 12, 2024
- Securities Issued: 500 shares of Series C Convertible Preferred Stock and warrants to purchase 4,223 shares of common stock.
- Proceeds from Transaction: $500,000
- Aggregate Program Status: As of December 13, 2024, the Purchaser (an affiliate) has purchased an aggregate of 48,100 shares of Series C Convertible Preferred Stock and warrants for 406,288 common shares.
- Total Aggregate Proceeds: $48.1 million
- Total Program Capacity: Up to $75 million
The filing does not provide specific data on revenue, net profit, operating cash flow, margins, debt levels, or liquidity ratios for the reporting period.
Material Changes
The primary material change is the increase in outstanding Series C Convertible Preferred Stock and associated warrants, raising the total capital raised under the agreement to $48.1 million. The filing does not disclose changes in operating performance or balance sheet metrics compared to prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of unregistered sales. The securities were sold in reliance on the exemption from registration requirements under Section 4(a)(2) of the Securities Act of 1933. The Purchaser is identified as an affiliate of the Company.
Key Facts for Investor Verification
- Verify the conversion terms and exercise price of the Series C Convertible Preferred Stock and Warrants referenced in the November 7, 2023 Form 8-K.
- Confirm the identity and relationship of the Purchaser, Ault & Company, Inc., as an affiliate.
- Assess the remaining capacity of the $75 million financing program ($26.9 million remaining).
- Review the dilution impact of the 406,288 warrant shares and the 48,100 preferred shares on existing common stockholders.